Blood Animation, Blood Illustrations

FDA Approves Most Comprehensive System To Test Donated Blood For HIV, Hepatitis B & Hepatitis C
The United States Food & Drug Administration (FDA) approved a new nucleic acid test from Roche to screen donated blood for HIV-1 Group M RNA, hepatitis C RNA and hepatitis B DNA in a single, automated assay. The test, called the cobas TaqScreen MPX Test for use on the cobas s 201 system, is a qualitative in vitro test for comprehensive single-assay detection of HIV-1 Group M RNA, HIV-1 Group O RNA, HIV-2 RNA, hepatitis C Virus RNA and hepatitis B Virus DNA in human plasma.

Replacing Old Blood With New Increases The Odds For Survival, TAU Researchers Find
"New blood" can revitalize a company or a sports team. Recent research by Tel Aviv University finds that young blood does a body good as well, especially when it comes to fighting cancer. The TAU researchers, led by Prof.

The Prevalence Of Gluten-sensitive Enteropathy In Iron-deficient Anemia Patients
Gluten sensitive enteropathy (GSE) is an autoimmune enteropathy due to food gluten intolerance in genetically predisposed people. While GSE was thought to be a rare disease in the past and was believed to be essentially a disease of Europeans, recent screening studies showed that GSE is one of the most frequent genetically based diseases occured worldwide.

Dengue Fever Could Be Controlled Via Mosquito Parasite
With laboratory-bred mosquitoes, scientists in Australia and China showed it may be possible to reduce the spread of dengue fever by using a parasite to shorten the life-span of the mosquito that carries the virus.

ACE-011 Phase 1 Results Published In The Journal Of Bone And Mineral Research
Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including bone, muscle and red blood cells and Celgene Corporation, today announced the publication of the ACE-011 Phase 1 clinical study demonstrating that ACE-011 increased biomarkers of bone formation, decreased biomarkers of bone resorption and increased hemoglobin levels in postmenopausal women.

Grape Seed Extract Kills Cancer Cells In Lab
A team of scientists from the US and China have discovered that grape-seed extract kills laboratory leukemia cells by making them commit suicide, thus showing the potential value of natural compounds in the treatment of cancer.

Grape Seed Extract Kills Laboratory Leukemia Cells, Proving Value Of Natural Compounds
An extract from grape seeds forces laboratory leukemia cells to commit cell suicide, according to researchers from the University of Kentucky. They found that within 24 hours, 76 percent of leukemia cells had died after being exposed to the extract. The investigators, who report their findings in the January 1, 2009, issue of

EU Grants VIDAZA® Full Marketing Authorization For The Treatment Of Patients With Higher-Risk Myelodysplastic Syndromes And Acute Myeloid Leukaemi
Celgene International Sàrl (Nasdaq:CELG) today announced that its cancer drug, VIDAZA (azacitidine), has been granted full marketing authorization by the European Commission for the treatment of adult patients who are not eligible for haematopoietic stem cell transplantation with: -- I

Bioreactors Might Solve Blood-Platelet Supply Problems
It might be possible to grow human blood platelets in the laboratory for transfusion, according to a new study at The Ohio State University Medical Center. The findings, published in the January 1, 2009 issue of the journal Experimental Hematology, might one day enable blood banks to grow platelets continuously and in quantities that can ease the chronically tight supply of these critical blood components.

Biomedical Researchers Create Artificial Human Bone Marrow In A Test Tube
Artificial bone marrow that can continuously make red and white blood cells has been created in a University of Michigan lab. This development could lead to simpler pharmaceutical drug testing, closer study of immune system defects and a continuous supply of blood for transfusions.

Study Shows Optimal Dose Management Of Warfarin Improves Anticoagulation Control
Researchers from Boston University School of Medicine (BUSM) have determined the optimal dose-management strategy to derive maximal benefit from warfarin therapy and improve patient outcomes. Results of the study appear online in the December 2008 issue of the Journal of Thrombosis and Haemostasis. Warfarin is highly effective to prevent strokes, treat venous thromboembolism and for other conditions.

FDA Approves Drug That Boosts Stem Cell Yield For Bone Marrow Transplants
The U.S. Food and Drug Administration approved Mozobil (plerixafor), a drug that helps increase the number of blood stem cells for bone marrow transplantation in patients with certain forms of blood cancer. Mozobil is intended to be used in combination with the growth factor granulocyte-colony stimulating factor (G-CSF), for treatment of adults with multiple myeloma or non-Hodgkin's lymphomas.

Blood Disorders Are A Pain In The Wallet, UK
People with sickle cell disease and thalassaemia must not be forgotten when the government review prescription charges, according to the All-Party Parliamentary Group (APPG) on Sickle Cell and Thalassaemia. The APPG on Sickle Cell and Thalassaemia met for the first time last week to address the health inequalities faced by sickle cell and thalassaemia patients in the UK.

Plavix Blood Thinner Effectiveness Influenced By Gene Variants
Two studies of heart patients showed that the blood thinner clopidogrel (brand name Plavix) was less effective in carriers of certain variants of a gene known to affect how the drug prevents blood clots than non-carriers. Both studies appear in the 22 December online issue of the New England Journal of Medicine, NEJM.

Diazyme Introduces Liquid Stable Enzymatic Lithium Test
Diazyme Laboratories announced recently that the U.S. Food and Drug Administration (FDA) has granted Diazyme 510(k) clearance to market its liquid stable enzymatic lithium test kit for the quantitative determination of lithium levels in blood samples. Compared to existing methods, the new Diazyme lithium assay provides improved reagent stability and a reduced cost per test. The assay features excellent accuracy and precision and offers an extended reportable range of 0.